Monday, October 1, 2018

Enesi Pharma and Public Health England Enter R&D Collaboration for Novel Needle-Free Solid-Dose Vaccine for Emergent Threat Pathogens

OXFORD, England, October 1, 2018 /PRNewswire/ -- Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose vaccine products, announces it has entered a research and development collaboration with Public Health England (PHE), an executive agency of...

from PR Newswire: //https://ift.tt/2NgiAAu

No comments:

Post a Comment